搜索结果: 16-30 共查到“国际动态 预防医学与卫生学 HIV”相关记录30条 . 查询时间(0.268 秒)
《艾滋病》：对HIV的天生免疫源于特殊基因(图)
艾滋病 基因
2008/7/18
有些人似乎对艾滋病具有天生的免疫力，他们经常处于艾滋高危环境中，却从不会被感染。加拿大科学家近日研究称，这可能要归功于他们体内同时表达了两种特殊基因——KIR3DL1和HLA-B*57。取决于拥有这两个基因的“版本”的不同，他们或是能抵御HIV感染，或是艾滋发展速度变慢。相关论文发表在《艾滋病》（AIDS）上。
领导此次研究的是加拿大麦吉尔大学健康中心的Nicole Bernard。研究人...
美国准备再次进行Ad5载体HIV疫苗临床试验
Ad5载体HIV疫苗 临床试验
2008/6/5
美国政府正准备开始一项新的艾滋病疫苗临床试验。这一举动引起了一些人的警告，毕竟在时间上这离去年默克疫苗的失败太近了。
上周末，美国国立卫生研究院（NIH）的艾滋病疫苗研究小组委员会以23比3的投票结果，赞同启动这项名为PAVE 100的HIV疫苗临床计划。该研究将由艾滋病疫苗评估伙伴组织（Partnership for AIDS Vaccine Evaluation，简称PAVE）负责实施...
愈挫愈勇 美国启动HIV疫苗“B计划”
动HIV疫苗“B计划”
2008/5/23
美国国立过敏与传染病研究所（NIAID）主任Anthony Fauci于2008年5月20日宣布，正式启动一项为期5年、1560万美元的项目，以支持免疫B细胞及以B细胞为标靶的HIV抑制抗体（neutralizing antibodies）研究。
PNAS：抑制特定酶活性能够阻断HIV复制（图）
PNAS 抑制特定酶活性 阻断HIV复制
2008/4/29
图片说明：HIV本身很难直接打击，标靶它的宿主细胞是个很好的替代方案。
（图片来源：Getty）
美国科学家近日研究发现，通过抑制某种酶的活性，能够阻断HIV在体内的传播。这一新颖的方法不仅有助于研发对付这一病毒的药物，更重要的是，由于它针对的不是HIV病毒本身，而是免疫系统中的蛋白，所以它回避了影响传统治疗方案效果的抗性问题。相关论文4月28日在线发表于美国《国家科学院院刊》（PNAS...
April 3, 2007,BLOOMINGTON, Ind. -- The charms of small-town living offer challenges, as well, for people with HIV, AIDS and STDs. Adequate support and treatment can be even more difficult to obtain fo...
Unhygienic Circumcision Procedures a Cause of HIV Infection Among African Adolescents
Psychology HIV infection epidemiology
2007/3/27
15 March 2007，Unhygienic circumcision procedures are a cause of HIV infection among African adolescents according to new research undertaken by Professor Stuart Brody, the University of Paisley’s Prof...
nternational Federation of Chemical, Energy, Mine HIV/AIDS e-bulletin - No. 17
HIV/AIDS Human Services
2007/2/6
1 February 2007，Of the one million Americans with HIV, some 250,000 do not know that they are infected. If they do not know, they will not seek treatment and they are more likely to infect others. The...
Joint Statement on Kenyan and Ugandan Trial Findings Regarding Male Circumcision and HIV
Male Circumcision HIV
2006/12/18
13 December 2006，Statement developed by the World Health Organization (WHO), the United Nations Population Fund (UNFPA), the United Nations Children’s Fund (UNICEF), the World Bank and the UNAIDS Secr...
New ILO report says HIV/AIDS epidemic costing more than 1 million new jobs per year Says workplace should become major entry point for prevention and access to treatment
child labour HIV/AIDS
2006/12/11
1 December 2006，GENEVA (ILO News) - The relentless advance of HIV/AIDS is markedly reducing economic and employment growth in countries hit hardest by the epidemic, jeopardizing their efforts to reduc...
The workforce and HIV/AIDS: Employment is a crucial lifeline
workforce HIV/AIDS Employment
2006/12/11
30 November 2006，recent study from Kenya (Note 2) covering 769 households showed that providing antiretroviral drug (ARV) therapy resulted in a large and immediate increase in the number of people wit...
Pharmaceutical Industry Fails in Developing Industry-Wide HIV/AIDS Initiative（图）
Pharmaceutical Industry HIV/AIDS
2006/12/4
Today, on World AIDS Day, 1 December, ICEM General Secretary Fred Higgs announced the collapse of talks on a promising global HIV/AIDS initiative which had the potential to save countless lives of tho...
Commissioner for Human Rights urges Ukrainian authorities to tackle growing HIV-AIDS crisis(图)
Human Rights HIV-AIDS
2006/11/30
Strasbourg, 29.11.2006 – Ukrainian authorities need to design a comprehensive national HIV/AIDS prevention strategy and dedicate more public funding to prevent the spread of the disease, said Thomas H...
November 14, 2006，Despite the enormous challenge that AIDS still poses to global health, for many people able to access antiretroviral treatment, HIV infection can now be managed as a chronic disease....
Partnership Delivering Services to Fight HIV/AIDS in The Pacific
Partnership Delivering Services HIV/AIDS Pacific
2006/11/23
20 November 2006，SYDNEY, AUSTRALIA - ADB is engaged in a partnership that is delivering HIV/AIDS prevention services in 10 small Pacific developing countries.
每天一次阿巴卡韦也可以有效对抗HIV感染
阿巴卡韦 HIV
2005/4/27
医业网2005年4月25日讯 据4月《获得性免疫缺陷综合征杂志》（J Acquir Immune Defic Syndr 2005;38:417—425）上的一项报告，阿巴卡韦每天一次与拉米夫定（3TC）、依法韦仑联用，可有效对抗HIV感染。